Buffett's Oil Bet + This 22% Dividend Play

Warren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occidental and Chevron) pay modest dividends of 1.47% and 4%, we've found a way for regular investors to potentially earn a much bigger income stream from the energy boom.

Christi Shaw Biography and Net Worth

Director of Avantor

Christi Shaw has served on our Board since November 2018 and is a member of the Compensation & Human Resources Committee and the Nominating & Governance Committee. Ms. Shaw currently serves as Chief Executive Officer of Kite, the cell therapy company of Gilead. Prior to this role, Ms. Shaw was Senior Vice President of Eli Lilly Company, and President of Lilly Bio-Medicines, the business within Eli Lilly Company that comprises neuroscience and immunology. In former roles, Ms. Shaw held several leadership roles, including U.S. Country Head and President of Novartis Pharmaceutical Corporation and North American Region Head of Novartis Oncology. Previously, Ms. Shaw has also held several leadership positions at Johnson & Johnson, Inc. Ms. Shaw serves as an executive board member of the Biotechnology Innovation Organization and is the co-founder of the More Moments More Memories Foundation to assist people with cancer and their caregivers. Ms. Shaw holds an MBA from the University of Wisconsin and a BBA in marketing from Iowa State University. Ms. Shaw’s extensive senior leadership experience within the healthcare industry and service as a Board Member of a large trade organization, along with her independence, make her a valuable member of our Board.

What is Christi Shaw's net worth?: The estimated net worth of Christi Shaw is at least $235,208.82 as of December 11th, 2020. Ms. Shaw owns 11,319 shares of Avantor stock worth more than $235,209 as of November 22nd. This net worth approximation does not reflect any other assets that Ms. Shaw may own. Learn More about Christi Shaw's net worth.
How do I contact Christi Shaw?: The corporate mailing address for Ms. Shaw and other Avantor executives is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. Avantor can also be reached via phone at (610) 386-1700 and via email at [email protected]. Learn More on Christi Shaw's contact information.
Has Christi Shaw been buying or selling shares of Avantor?: Christi Shaw has not been actively trading shares of Avantor during the last quarter. Most recently, Christi Shaw sold 14,286 shares of the business's stock in a transaction on Friday, December 11th. The shares were sold at an average price of $26.68, for a transaction totalling $381,150.48. Following the completion of the sale, the director now directly owns 11,319 shares of the company's stock, valued at $301,990.92. Learn More on Christi Shaw's trading history.
Who are Avantor's active insiders?: Avantor's insider roster includes James Bramwell (EVP), Gerard Brophy (EVP), Christophe Couturier (EVP), Steven Eck (CAO), Rajiv Gupta (Director), Justin Miller (EVP), Jo Natauri (Director), Devashish Ohri (EVP), Christi Shaw (Director), Michael Stubblefield (CEO), Thomas Szlosek (CFO), Frederic Vanderhaegen (EVP), and Michael Wondrasch (EVP). Learn More on Avantor's active insiders.
Are insiders buying or selling shares of Avantor?: In the last twelve months, insiders at the sold shares 2 times. They sold a total of 9,728 shares worth more than $240,247.97. The most recent insider tranaction occured on September, 5th when CAO Steven W Eck sold 3,525 shares worth more than $88,336.50. Insiders at Avantor own 1.5% of the company. Learn More about insider trades at Avantor.
Information on this page was last updated on 9/5/2024.

Christi Shaw Insider Trading History at Avantor

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/11/2020	Sell	14,286	$26.68	$381,150.48	11,319

Christi Shaw Buying and Selling Activity at Avantor

Avantor Company Overview

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Today's Range

Now: $20.78

$20.25

$20.85

50 Day Range

MA: $24.01

$19.72

$27.70

2 Week Range

Now: $20.78

$19.59

$28.00

Volume

7,456,697 shs

Average Volume

6,501,795 shs

Market Capitalization

$14.14 billion

P/E Ratio

45.17

Dividend Yield

N/A

Beta

1.35

Buffett's Oil Bet + This 22% Dividend Play

From Investors Alley | Ad

Click here to get the full story >>